TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM $3.71B
1-Year Return
19.93%
This Quarter Return
-3.2%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$3.36B
AUM Growth
-$1.68B
(-33%)
Cap. Flow
-$1.35B
Cap. Flow
% of AUM
-40.17%
Top 10 Holdings %
Top 10 Hldgs %
28.65%
Holding
6,080
New
403
Increased
1,949
Reduced
2,725
Closed
953
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$249M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$21M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$18.3M |
| 4 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$15.6M |
| 5 |
Exxon Mobil
XOM
|
+$14.9M |
Top Sells
| 1 |
Apple
AAPL
|
+$120M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$94.5M |
| 3 |
Microsoft
MSFT
|
+$85.3M |
| 4 |
NVIDIA
NVDA
|
+$83M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
+$38.8M |
Sector Composition
| 1 | Technology | 19.99% |
| 2 | Financials | 9.87% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Healthcare | 7.96% |
| 5 | Communication Services | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Taylor Devices
TAYD
$153M
| $9.26K | ﹤0.01% |
287
-46
| -14% | -$1.48K |
|
3802
Nautilus Biotechnolgy
NAUT
$94.8M
| $9.26K | ﹤0.01% |
10,754
-2,477
| -19% | -$2.13K |
|
3803
HireQuest
HQI
$136M
| $9.26K | ﹤0.01% |
778
-51
| -6% | -$607 |
|
|
RAPP
3804
Rapport Therapeutics
RAPP
$1.2B
| $9.25K | ﹤0.01% |
922
+181
| +24% | +$1.82K |
|
3805
ProFrac Holding
ACDC
$693M
| $9.25K | ﹤0.01% |
1,218
-650
| -35% | -$4.93K |
|
|
WW
3806
DELISTED
WW International
WW
| $9.24K | ﹤0.01% |
17,679
+16,335
| +1,215% | +$8.54K |
|
3807
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$846M
| $9.23K | ﹤0.01% |
189
-5,586
| -97% | -$273K |
|
3808
Atossa Therapeutics
ATOS
$106M
| $9.22K | ﹤0.01% |
13,697
+253
| +2% | +$170 |
|
3809
MarketWise
MKTW
$47.6M
| $9.22K | ﹤0.01% |
934
-82
| -8% | -$809 |
|
3810
Xeris Biopharma Holdings
XERS
$1.2B
| $9.2K | ﹤0.01% |
1,717
-2,218
| -56% | -$11.9K |
|
|
CMRC
3811
Commerce.com, Inc. Series 1 Common Stock
CMRC
$397M
| $9.2K | ﹤0.01% |
1,597
-36,039
| -96% | -$208K |
|
3812
Pure Cycle
PCYO
$270M
| $9.18K | ﹤0.01% |
877
+123
| +16% | +$1.29K |
|
|
MAZE
3813
Maze Therapeutics, Inc. Common Stock
MAZE
$1.01B
| $9.18K | ﹤0.01% |
+834
| New | +$9.18K |
|
|
BCYC
3814
Bicycle Therapeutics
BCYC
$483M
| $9.18K | ﹤0.01% |
1,081
+156
| +17% | +$1.32K |
|
|
GCTS
3815
GCT Semiconductor Holding
GCTS
$85.5M
| $9.18K | ﹤0.01% |
5,596
+1,373
| +33% | +$2.25K |
|
3816
Genasys
GNSS
$103M
| $9.17K | ﹤0.01% |
+4,041
| New | +$9.17K |
|
3817
OP Bancorp
OPBK
$212M
| $9.17K | ﹤0.01% |
763
+281
| +58% | +$3.38K |
|
3818
Butterfly Network
BFLY
$408M
| $9.17K | ﹤0.01% |
4,021
-71,114
| -95% | -$162K |
|
3819
Alto Neuroscience
ANRO
$105M
| $9.15K | ﹤0.01% |
4,237
+1,545
| +57% | +$3.34K |
|
|
REFI
3820
Chicago Atlantic Real Estate Finance
REFI
$282M
| $9.1K | ﹤0.01% |
619
-2,048
| -77% | -$30.1K |
|
3821
iHeartMedia
IHRT
$447M
| $9.09K | ﹤0.01% |
5,511
-3,523
| -39% | -$5.81K |
|
3822
Inovio Pharmaceuticals
INO
$121M
| $9.09K | ﹤0.01% |
5,614
-2,876
| -34% | -$4.66K |
|
|
AUTL
3823
Autolus Therapeutics
AUTL
$351M
| $9.08K | ﹤0.01% |
5,857
+1,127
| +24% | +$1.75K |
|
3824
Puma Biotechnology
PBYI
$229M
| $9.08K | ﹤0.01% |
3,066
-7,071
| -70% | -$20.9K |
|
3825
Catalyst Pharmaceutical
CPRX
$2.45B
| $9.07K | ﹤0.01% |
374
-26,117
| -99% | -$633K |
|